Denver, CO – April 19th – 22th, 2023 – SynCardia demonstrates prototypes for the upgraded Freedom Hush driver and the new Liberty driver at ISHLT in Denver.
Close On The Heels Of The Recent FDA Approval Of The Software Upgrades To The Freedom Driver, Team SynCardia Was Out In Force At The Annual Conference Of International Society For Heart And Lung Transplantation (ISHLT) In Denver Apr 19-22, 2023.
Among the many updates provided were demonstrations of:
- Software updates available from May 1 that improves “Cardiac Output measurement accuracy”, particularly for the new 50cc implant
- Prototype Freedom Hush Driver that is expected to be significantly softer than the current Freedom Driver
- New driver features that may allow physicians to access continuous and real-time readings of a patient’s Right and Left Atrial Pressures (RAP/LAP), the Pulmonary Arterial Pressure (RAP), and Systolic/Diastolic Arterial Pressure in the future
- Next-gen “Liberty” portable driver that is expected to be at a fraction of the weight and size of the current Freedom Drivers
The Freedom Hush and Liberty Drivers, as well as the pressure reading features are currently not approved for patient use in the US and in Europe. What were demonstrated are advanced engineering prototypes in varying stages of design control. For more information, please contact email@example.com
In one of the more light-hearted sessions in the conference, ChatGPT concurred with a voting audience of cardiologists and transplant surgeons, that the Total Artificial Heart (TAH) was preferred over a durable LVAD for the treatment of a hypothetical patient with biventricular failure.
Team SynCardia hopes to see everyone again at ASAIO 2023 and HFSA 2023 with further updates on these exciting developments. Stay tuned!